DRUG · Mapped RxNorm record
Pimecrolimus
Normalized identity: pimecrolimusView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Safety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification
NCT00124709
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
Corticosteroid
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedSafety and Efficacy of Pimecrolimus Cream 1% in Atopic Disease Modification
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Atopic Dermatitisverified · MONDO: atopic eczema
Interventions
PimecrolimusDRUG · verified · RxNorm: pimecrolimus
CorticosteroidDRUG
Sponsors & collaborators
Novartis Pharmaceuticalslead sponsor
Mapped research locations
New YorkNew York, United States1HoustonTexas, United States1BostonMassachusetts, United States1ChicagoIllinois, United States1PhiladelphiaPennsylvania, United States1BaltimoreMaryland, United States1St LouisMissouri, United States1NashvilleTennessee, United States1SeattleWashington, United States1PittsburghPennsylvania, United States1BirminghamAlabama, United States1San DiegoCalifornia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00124709 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.